Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Head and Neck Pathology
Published in: Head and Neck Pathology 1/2020

Open Access 01-03-2020 | Hemangioma | Special Issue: Soft Tissue

Soft Tissue Special Issue: Perivascular and Vascular Tumors of the Head and Neck

Authors: Uta Flucke, Marie Karanian, Roel W. ten Broek, Khin Thway

Published in: Head and Neck Pathology | Issue 1/2020

Login to get access

Abstract

Perivascular and vascular neoplasms of the head and neck are a rare group of tumors comprising a spectrum of clinical/biologic and histological features. They are frequently diagnostically challenging, due to their morphologic and immunohistochemical overlap. In this review, we summarize the pathology of these neoplasms, discussing morphology, immunohistochemistry, associated genetic findings, and the differential diagnoses.
Literature
1.
Granter SR, Badizadegan K, Fletcher CD. Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol. 1998;22:513–25.PubMed
2.
Fletcher CD. Distinctive soft tissue tumors of the head and neck. Mod Pathol. 2002;15:324–30.PubMed
3.
Mentzel T, Dei Tos AP, Sapi Z, Kutzner H. Myopericytoma of skin and soft tissues. Clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2006;30:104–13.PubMed
4.
Coffin CM, Alaggio R. Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol. 2012;15(1 Suppl):127–80.PubMed
5.
Agaimy A, Bieg M, Michal M, Geddert H, Märkl B, Seitz J, Moskalev EA, Schlesner M, Metzler M, Hartmann A, Wiemann S, Michal M, Mentzel T, Haller F. Recurrent somatic PDGFRB mutations in sporadic infantile/solitary adult myofibromas but not in angioleiomyomas and myopericytomas. Am J Surg Pathol. 2017;41:195–203.PubMed
6.
Antonescu CR, Sung YS, Zhang L, Agaram NP, Fletcher CD. Recurrent SRF-RELA fusions define a novel subset of cellular variants in the myofibroma/myopericytoma spectrum: a potentialdiagnostic pitfall with sarcomas with myogenicdifferentiation. Am J Surg Pathol. 2017;41:677–84.PubMedPubMedCentral
7.
Matsuyama A, Hisaoka M, Hashimoto H. Angioleiomyoma: a clinicopathologic and immunohistochemical reappraisal with special reference to the correlation with myopericytoma. Hum Pathol. 2007;38:645–51.PubMed
8.
Liu Y, Li B, Li L, Liu Y, Wang C, Zha L. Angioleiomyomas in the head and neck: a retrospective clinical and immunohistochemical analysis. Oncol Lett. 2014;8:241–7.PubMedPubMedCentral
9.
Agaimy A, Michal M, Thompson LD, Michal M. Angioleiomyoma of the sinonasal tract: analysis of 16 cases and review of the literature. Head Neck Pathol. 2015;9:463–73.PubMedPubMedCentral
10.
Miettinen M. Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis. Mod Pathol. 2014;27(Suppl 1):S27–9.
11.
Coutinho-Camillo CM, Brentani MM, Nagai MA. Genetic alterations in juvenile nasopharyngeal angiofibromas. Head Neck. 2008;30:390–400.PubMed
12.
Thway K, Fisher C, Sebire NJ. Pediatric fibroblastic and myofibroblastic lesions. Adv Anat Pathol. 2012;19:54–6.PubMed
13.
McKnight CD, Parmar HA, Watcharotone K, Mukherji SK. Reassessing the anatomic origin of the juvenile nasopharyngeal angiofibroma. J Comput Assist Tomogr. 2017;41:559–64.PubMed
14.
Abraham SC, Montgomery EA, Giardiello FM, Wu TT. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol. 2001;158:1073–8.PubMedPubMedCentral
15.
Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma. A clinicopatholoc and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003;27:737–49.PubMed
16.
Lasota J, Felisiak-Golabek A, Aly FZ, Wang ZF, Thompson LD, Miettinen M. Nuclear expression and gain-of-function beta-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker. Mod Pathol. 2015;28:715–20.PubMed
17.
Haller F, Bieg M, Moskalev EA, Barthelmess S, Geddert H, Boltze C, Diessel N, Braumandl K, Brors B, Iro H, Hartmann A, Wiemann S, Agaimy A. Recurrent mutations within the amino-terminal region of beta-catenin are probable key molecular driver events in sinonasal hemangiopericytoma. Am J Pathol. 2015;185:563–71.PubMed
18.
Johncilla M, Jo VY. Soft tissue tumors of the sinonasal tract. Semin Diagn Pathol. 2016;33:81–90.PubMed
19.
Lu VM, Marek T, Gilder HE, Puffer RC, Raghunathan A, Spinner RJ, Daniels DJ. H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications. J Neurooncol. 2019;144:433–43.PubMed
20.
Lewis JT, Oliveira AM, Nascimento AG, Schembri-Wismayer D, Moore EA, Olsen KD, Garcia JG, Lonzo ML, Lewis JE. Low-grade sinonasal with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol. 2012;36:517–25.PubMed
21.
Le Loarer F, Laffont S, Lesluyes T, Tirode F, Antonescu A, Baglin AC, Delespaul L, Soubeyran I, Hostein I, Pèrot G, Chibon F, Baud J, Guellec L, Karanian M, Costes-Martineau V, Castain C, Eimer S, Le Bail B, Wassef M, Coindre JM. Clinicopathologic and molecular features of a series of 41 biphenotypic sinonasal sarcomas expanding their molecular spectrum. Am J Surg Pathol. 2019;43:747–54.PubMed
22.
Mosquera JM, Sboner A, Zhang L, Chen CL, Sung YS, Chen HW, Agaram NP, Briskin D, Basha BM, Singer S, Rubin MA, Tuschl T, Antonescu CR. Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes Chromosom Cancer. 2013;52:1075–87.PubMed
23.
Mravic M, LaChaud G, Nguyen A, Scott MA, Dry SM, James AW. Clinical and histopathological diagnosis of glomus tumor: an institutional experience of 138 cases. Int J Surg Pathol. 2015;23:181–8.PubMedPubMedCentral
24.
Zou H, Song L, Jia M, Wang L, Sun Y. Glomus tumor in the floor of the mouth: a case report and review of the literature. World J Surg Oncol. 2018;16:201.PubMedPubMedCentral
25.
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. WHO classification of tumors of soft tissue and bone. IARC: Lyon; 2013.
26.
North PE. Pediatric vascular tumors and malformations. Surg Pathol. 2010;3:455–94.
27.
North PE. Classification and pathology of congenital and perinatal vascular anomalies of the head and neck. Otolaryngol Clin N Am. 2018;51:1–39.
28.
North PE, Waner M, Buckmiller L, James CA, Mihm MC. Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol. 2006;15:303–17.PubMed
29.
Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, Burrows P, Frieden IJ, Garzon MC, Lopez-Gutierrez JC, Lord DJ, Mitchel S, Powell J, Prendiville J, Vikkula M, ISSVA board and Scientific Committee. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015;136:e203–14.PubMed
30.
Adams DM, Ricci KW. Infantile hemangiomas in the head and neck region. Otolaryngol Clin Am. 2018;51:77–87.
31.
Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390:85–94.PubMed
32.
Ayturk UM, Couto JA, Hann S, Mulliken JB, Williams KL, Huang AY, Fishman SJ, Boyd TK, Kozakewich HP, Bischoff J, Greene AK, Warman ML. Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma. Am J Hum Genet. 2016;98:789–95.PubMedPubMedCentral
33.
Fetch JF, Sesterhenn IA, Miettinen M, Davis CJ. Epithelioid hemangioma of the penis. A clinicopathologic and immunohistochemical analysis of 19 cases, with special reference to exuberant examples often confused with epithelioid hemangioendothelioma and epithelioid angiosarcoma. Am J Surg Pathol. 2004;28:523–33.
34.
Flucke U, Vogels RJ, Somerhausen NSA, Creytens DH, Riedl RG, van Gorp JM, Milne AN, Huysentuyt CJ, Verdijk MA, van Asseldonk MM, Suurmeijer AJ, Bras J, Palmedo G, Groenen PJ, Mentzel T. Epithelioid hemangioendothelioma: clinicopathologic, immunohistochemical and molecular genetic analysis of 39 cases. Diagn Pathol. 2014;9:131.PubMedPubMedCentral
35.
Huang SC, Zhang L, Sung YS, Chen CL, Krausz T, Dickson BC, Kao YC, Agaram NP, Fletcher CD, Antonescu CR. Frequent FOS gen rearrangements in epithelioid hemangioma: a molecular study of 58 cases with morphologic reappraisal. Am J Surg Pathol. 2015;39:1313–21.PubMedPubMedCentral
36.
Hung YP, Fletcher CD, Hornick JL. FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma. Am J Surg Pathol. 2017;41:596–606.PubMed
37.
Shon W, Billings SD. Epithelioid vascular tumors: a review. Adv Anat Pathol. 2019;26:186–97.PubMed
38.
Papke DJ Jr, Hornick JL. What’s new in endothelial neoplasia? Virch Arch. 2019;10(2):69–87.
39.
Brenn T, Fletcher CD. Cutaneous epithelioid angiomatous nodule: a distinct lesion in the morphologica spectrum of epithelioid vascular tumors. Am J Dermatopathol. 2004;26:14–21.PubMed
40.
Shibuya R, Matsuyama A, Shiba E, Harada H, Yabuki K, Hisaoka M. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Histopathology. 2015;67:827–35.PubMed
41.
Blei F. Overgrowth syndromes with vascular anomalies. Curr Probl Pediatr Adolesc Health Care. 2015;45:118–31.PubMed
42.
Trindade F, Tellechea O, Torrelo A, Requena L, Colmenero I. Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol. 2011;33:569–72.PubMed
43.
Ten Broek RW, Eijkelenboom A, van der Vleuten CJ, Kamping EJ, Kets M, Verhoeven BH, Grünberg K, Schultze Kool LJ, Tops BB, Ligtenberg MJ, Flucke U. Comprehensive molecular and clinicopathological analysis of vascular malformations: a study of 319 cases. Genes Chromosom Cancer. 2019;58:541–50.PubMed
44.
Brouillard P, Boon LM, Mulliken JB, Enroljas O, Ghassibé M, Warman ML, Tan OT, Olsen BR, Vikkula M. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”). Am J Hum Genet. 2002;70:866–74.PubMedPubMedCentral
45.
Dossett LA, Harrington M, Cruse CW, Gonzalez RJ. Cutaneous angiosarcoma. Curr Probl Cancer. 2015;39:258–63.PubMed
46.
Lee KC, Chuang SK, Philipone EM, Peters SM. Characteristics and prognosis of primary head and neck angiosarcomas: a surveillance, epidemiologie, and end results program (SEER) analysis of 1250 cases. Head Neck Pathol. 2019;13:378–85.PubMed
47.
Ishida Y, Otsuka A, Kabashima K. Cutaneous angiosarcoma: update on biology and latest treatment. Curr Opin Oncol. 2018;30:107–12.PubMedPubMedCentral
48.
Flucke U, Requena L, Mentzel T. Radiation-induced vascular lesions of the skin: an overwiew. Adv Anat Pathol. 2013;20:407–15.PubMed
49.
Miettinen M, Wang ZF, Paetau A, Tan SH, Dobi A, Srivastava S, Sesterhenn I. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Am J Surg Pathol. 2011;35:432–41.PubMedPubMedCentral
50.
Tarabishy Y, Montgomery EA. Vascular tumors of intermediate malignancy and angiosarcoma: a review. AJSP Rev Rep. 2017;22:108–15.
51.
Thum C, Husain EA, Mulholland K, Hornick JL, Brenn T. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma. Ann Diagn Pathol. 2013;17(6):502–7.PubMed
52.
Weidema ME, Versleijen-Jonkers YMH, Flucke UE, Desar IME, van der Graaf WTA. Targeting angiosarcomas of the soft tissues: a challenging effort in a heterogeneous and rare disease. Crit Rev Oncol Hematol. 2019;138:120–31.PubMed
53.
Shon W, Sukov WR, Jenkins SM, Folpe AL. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in situ hybridization and immunohistochemical study. Mod Pathol. 2014;27:509–15.PubMed
54.
Deyrup AT, Tighiouart M, Montag A, Weiss SW. Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol. 2008;32:924–7.PubMed
55.
Errani C, Zhang L, Sung YS, Hajdu M, Singer S, Maki RG, Healey JH, Antonescu CR. A novel WWTR1-CAMRA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosom Cancer. 2011;50:644–53.PubMed
56.
Antonescu CR, Le Loarer F, Mosquera J, Sboner A, Zhang L, Chen C, Chen H, Pathan N, Krausz T, Dickson B, Weinreb I, Rubin M, Hameed M, Fletcher CD. Novel YAP-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosom Cancer. 2013;52:775–84.PubMed
57.
Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982;50:970–81.PubMed
58.
Mentzel T, Beham A, Calonje E, Katenkamp D, Fletcher CD. Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol. 1997;21:363–74.PubMed
59.
Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer. 1999;85:562–82.PubMed
60.
Wu X, Li B, Zheng C, Hong T, He X. Clinical characteristics of epithelioid hemangioendothelioma: a single-center retrospective study. Eur J Med Res. 2019;24:16.PubMedPubMedCentral
61.
Hornick JL, Fletcher CD. Pseudomyogenic hemangioendothelioma: a distinctive often multicentric tumor with indolent behavior. Am J Surg Pathol. 2011;35:190–201.PubMed
62.
Billings SD, Folpe AL, Weiss SW. Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol. 2003;27(1):48–57.PubMed
63.
Walther C, Tayebwa J, Lilljebjörn H, Magnusson L, Nilsson J, Von Steyern FV, Ora I, Domanski HA, Fioretos T, Nord KH, Fletcher CDM, Mertens F. A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma. J Pathol. 2014;232(5):534–40.PubMed
64.
Zhu G, Benayed R, Ho C, Mullaney K, Sukhadia P, Rios K, Berry R, Rubin BP, Nafa K, Wang L, Klimstra DS, Ladany M, Hameed MR. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma. Mod Pathol. 2019;32(5):609–20.PubMed
65.
66.
Croteau SE, Liang MG, Kozakewich HP, Alomari AL, Fishman SJ, Mulliken JB, et al. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach–Merritt-phenomenon in 107 referrals. J Pediatr. 2013;162:142–7.PubMed
67.
Wong BL, Lee VN, Tikka T, Kim D, Dwivedi RC. Kaposiform haemangioendothelioma of the head and neck. Crit Rev Oncol Hematol. 2016;104:156–68.PubMed
68.
Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach–Merritt syndrome and lymphangiomatosis. Am J Surg Pathol. 1993;17:321–8.PubMed
69.
Putra J, Gupta A. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis. Pathology. 2017;49:356–62.PubMed
70.
Lyons LL, North PE, Mac-Moune Lai F, Stoler MH, Folpe AL, Weiss SW. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol. 2004;28:559–68.PubMed
71.
Chu CY, Hsiao CH, Chiu HC. Transformation between kaposiform hemangioendothelioma and tufted angioma. Dermatology. 2003;206:334–7.PubMed
72.
Lim YH, Bacchiocchini A, Qiu J, Straub R, Bruckner A, Bercovitch L, Narayan D, McNiff J, Ko C, Robinson-Bostom L, Antaya R, Halabun R, Choate KA. GNA14 mutation causes congenital and sporadic vascular tumors by MAPK activation. Am J Hum Genet. 2016;99:443–50.PubMedPubMedCentral
73.
Bean GR, Joseph NM, Folpe AL, Horwai AE, Umetsu SE. Recurrent GNA14 mutations in anastomosing hemangiomas. Histopathology. 2018;73:351–62.
74.
Joseph NM, Brunt EM, Marginean C, Nalbantoglu I, Snover DC, Thung SN, Yeh MM, Umetsu S, Ferrell L, Gill RM. Frequent GNAQ and GNA14 mutations in hepatic small vessel neoplasm. Am J Surg Pathol. 2018;42:1201–7.PubMed
75.
Croteau SE, Kozakewich HP, Perez-Atayde AR, Fishman SJ, Alomari AI, Chaudry G, Mulliken JB, Trenor CC. Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly. J Pediatr. 2014;164:383–8.PubMed
76.
Ten Broek RW, Bekers EM, de Leng WWJ, Strengman E, Tops BBJ, Kutzner H, Leeuwis JW, van Gorp JM, Creytens DH, Mentzel T, van Diest PJ, Eijkelenboom A, Flucke U. Mutational analysis using Sanger and next generation sequencing in sporadic spindle cell hemangiomas: a study of 19 cases. Genes Chromosom Cancer. 2017;56:855–60.PubMed
Metadata
Title
Soft Tissue Special Issue: Perivascular and Vascular Tumors of the Head and Neck
Authors
Uta Flucke
Marie Karanian
Roel W. ten Broek
Khin Thway
Publication date
01-03-2020
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2020
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-020-01129-z

Other articles of this Issue 1/2020

Head and Neck Pathology 1/2020 Go to the issue

Original Paper

Inter-observer Variability in the Diagnosis of Proliferative Verrucous Leukoplakia: Clinical Implications for Oral and Maxillofacial Surgeon Understanding: A Collaborative Pilot Study

Special Issue: Soft Tissue

Soft Tissue Special Issue: Selected Topics in the Pathology of Adipocytic Tumors

Special Issue: Soft Tissue

Soft Tissue Special Issue: Myoepithelial Neoplasms of Soft Tissue: An Updated Review with Emphasis on Diagnostic Considerations in the Head and Neck

Special Issue: Soft Tissue

Soft Tissue Special Issue: Biphenotypic Sinonasal Sarcoma: A Review with Emphasis on Differential Diagnosis

Sine qua non Clinicopathologic Correlation

Congenital Granular Cell Epulis: Classic Presentation and Its Differential Diagnosis

Sine qua non Radiology-Pathology

Regional Odontodysplasia Affecting the Maxilla